Literature DB >> 2768447

Antigen-antibody reaction in solution in capture competition immunoassay for human immunodeficiency virus antibodies.

C M Nielsen1, B Kvinesdal, B F Vestergaard.   

Abstract

In the capture competition immunoassay, undiluted serum was reacted in solution with purified human immunodeficiency virus (HIV) antigen in wells of microtest plates coated with anti-HIV immunoglobulin G antibodies (HIV capture antibodies). HIV antibodies present in the serum being tested combined with the HIV antigen and thus blocked (completely or partially) the fixation of the antigen to the capture layer. Unblocked antigenic activity was measured in subsequent steps by the use of biotinylated anti-HIV immunoglobulin G and peroxidase-conjugated avidin. The assay was evaluated in comparison with indirect enzyme-linked immunosorbent assay and Western (immuno-) blot (WB). A total of 180 serum samples which reacted repeatedly as positive in indirect enzyme-linked immunosorbent assay but negative in WB were found to be negative by the capture competition assay. Of 54 serum samples showing dubious reactions (single p24 bands in WB), 53 were clearly separated into positive or negative reactions, whereas 1 serum sample gave a borderline reaction. It was concluded that a characteristic feature of this kind of inhibition assay is a very low frequency of equivocal results.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2768447      PMCID: PMC267623          DOI: 10.1128/jcm.27.7.1609-1612.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  A biotin-avidin-amplified inhibition enzyme immunoassay for detection of CMV antibodies in human serum.

Authors:  C M Nielsen; K Hansen; H M Andersen; J Gerstoft; B F Vestergaard
Journal:  J Virol Methods       Date:  1987-06       Impact factor: 2.014

2.  Continuous production of a cytopathic human T-lymphotropic virus in a permissive neoplastic T-cell line.

Authors:  J P Getchell; J L Heath; D R Hicks; C Sporborg; C R McGrath; V S Kalyanaraman
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

3.  Anti-HTLV III ELISA and Western blot testing in a blood donor population: implications for donor notification.

Authors:  S Kleinman; H Anton-Guirigis; B D Culver; T H Taylor; H E Prince; H S Kaplan
Journal:  Vox Sang       Date:  1986       Impact factor: 2.144

4.  Blood donor sera with false-positive Western blot reactions to human immunodeficiency virus.

Authors:  G Biberfeld; U Bredberg-Rådén; B Böttiger; P O Putkonen; J Blomberg; P Juto; G Wadell
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

5.  False-positive Western blot reactions to human immunodeficiency virus in blood donors.

Authors:  A M Couroucé; J Y Muller; D Richard
Journal:  Lancet       Date:  1986-10-18       Impact factor: 79.321

6.  HLA DR4 antibodies cause positive HTLV-III antibody ELISA results.

Authors:  P Kühnl; S Seidl; G Holzberger
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

7.  Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection.

Authors:  C Pedersen; C M Nielsen; B F Vestergaard; J Gerstoft; K Krogsgaard; J O Nielsen
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-05

8.  Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).

Authors:  A R Neurath; N Strick; P Sproul; L Baker; P Rubinstein; C E Stevens; P Taylor; R C Gallo; J W Gold; Y S Lee
Journal:  J Virol Methods       Date:  1985-05       Impact factor: 2.014

9.  Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III.

Authors:  J W Ward; A J Grindon; P M Feorino; C Schable; M Parvin; J R Allen
Journal:  JAMA       Date:  1986-07-18       Impact factor: 56.272

10.  Evaluation of six enzyme immunoassays for antibody against human immunodeficiency virus.

Authors:  H W Reesink; P N Lelie; J G Huisman; W Schaasberg; M Gonsalves; C Aaij; I N Winkel; J A van der Does; A C Hekker; J Desmyter
Journal:  Lancet       Date:  1986-08-30       Impact factor: 79.321

View more
  1 in total

1.  Immunofluorescence assay for detection of antibodies to human immunodeficiency virus type 2.

Authors:  B B Kvinesdal; C M Nielsen; A G Poulsen; N Højlyng
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.